Iraqi Forces Capture Senior ISIS Commander in Anbar Raid

Iraq’s National Security Service announced the successful...

Bahrain Launches Digital Property Title Service

Bahrain has introduced a new Digital Property...

Bahrain Strengthens GCC Unity and Regional Cooperation

The Kingdom of Bahrain continues to advance...
HomeLifestyleHMC Performs Qatar’s...

HMC Performs Qatar’s First Frozen Red Blood Cell Transfusion Successfully

Hamad Medical Corporation’s (HMC) Laboratory Medicine and Pathology Department recently completed Qatar’s first-ever blood transfusion using frozen red cells. This marks a major breakthrough in treating patients with complex blood conditions and special needs.

The patient suffered from Thalassemia Major and faced several immune system challenges. After the transfusion, doctors reported no adverse reactions. Instead, the patient’s hemoglobin levels stabilized, organ function improved, and overall health got better. Therefore, this success offers new hope for patients with rare blood types.

This achievement was possible thanks to HMC’s newly created frozen red cells stock. These blood cells are stored at ultra-low temperatures, allowing them to remain usable for up to 30 years. Consequently, this long-term storage helps maintain a steady supply of rare blood types for patients who need hard-to-match transfusions.

Before transfusion, the frozen blood cells undergo a careful thawing and washing process. This process removes protective chemicals and ensures a safer and more precise match for the patient. Moreover, it is especially vital for patients with rare blood groups or complex antibodies, who often face difficulties in finding compatible blood.

Dr. Einas Al Kuwari, Chair of Clinical Services at HMC, called this a key step forward in blood transfusion care. “Frozen red cells solve many long-standing problems,” she said. “They allow us to give life-saving blood exactly when patients need it, safely and precisely.”

Furthermore, she added that this breakthrough shows HMC’s dedication to patient-focused care. “This first transfusion opens the door to advanced blood treatments in Qatar,” Dr. Al Kuwari explained.

Looking ahead, HMC plans to expand the use of frozen red cells to help more patients with difficult transfusion needs. This will reduce shortages of rare blood types and improve treatment success across the region.

As a regional healthcare leader, HMC continues to invest in new technologies and patient-centered solutions. In summary, this achievement highlights Qatar’s commitment to advancing healthcare quality through modern, innovative methods.

Submit Your Article

Share your story with Khaleej Telegraph readers

Minimum 300 words recommended

Our editorial team will review your submission within 48 hours

Continue reading

Last Chance to Visit Mathaf Spring 2025 Exhibitions Before August 9 Closure

Arab Museum of Modern Art urges art lovers to visit its ongoing Mathaf Spring 2025 exhibitions. These exhibitions will close on August 9. They are part of the Qatar Creates Spring/Summer 2025 season and offer a rare opportunity. Art lovers can explore Qatari...

Israeli Sovereignty Over West Bank Condemned by Qatar, Allies, and International Groups

The State of Qatar, along with nine nations, the Arab League, and the Organization of Islamic Cooperation (OIC), has strongly condemned the Israeli Knesset’s recent decision to extend "Israeli sovereignty over West Bank." This move, according to the joint statement,...

Portfolio Decarbonisation Strategy by Msheireb Properties Sets New Sustainability Benchmark

Msheireb Properties has officially launched a groundbreaking portfolio decarbonisation strategy in partnership with global consultancy Cundall. Notably, this ambitious initiative targets the developer’s entire real estate portfolio in Msheireb Downtown Doha. Importantly, this project is the first of its kind at this...